In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
Join us to investigate the latest technological innovations, benchmark against your peers, build global connections and streamline your drug development pipelines for food allergy, with insights being shared from a range of companies and institutions including Aimmune, Camallergy, Allergy Therapeutics, Intrommune, Vedanta Biosciences and University of North Carolina.
Access the official event guide to learn more.
Attending Companies Include:
Industry-Leading Speakers Include:
Professor, Pediatric Allergy
Kings College London
Principal Scientist, Innovation & Product Development
Senior Medical Advisor/ Associate Professor
Intrommune Therapeutics/Weill Cornell Medical College